Open access journal of the Ferrata-Storti Foundation, a non-profit organization
Letters to the Editor

TET2 mutation does not impact the prognosis of adult acute myeloid leukemia patients receiving a hematopoietic stem cell transplantation in first remission: similar outcome following matched sibling and unrelated versus haploidentical donor transplants in a multi-center retrospective analysis from the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation

Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
EBMT Paris Study Unit, Hôpital Saint Antoine, Paris
EBMT Paris Study Unit, Hôpital Saint Antoine, Paris
The First Affiliated Hospital of Soochow University, SUZHOU
The First Affiliated Hospital of Soochow University, SUZHOU
University Medical Center Hamburg, Hamburg
University Hospital | Basel, Basel
Dept of Hematology, Helsinki University Hospital Comprehensive Cancer Center and University of Helsinki, Helsinki
Department of Clinical Haematology and Stem Cell Transplant Unit, University Hospital Turku, Turku
Section of hematology, Institut Roi Albert II, Cliniques Universitaires St-Luc, Brussels
Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover
University Hospital Gasthuisberg, Leuven
University Hospital Birmingham NHS Trust, Stoke
Rigshospitalet, Copenhagen
Aarhus University Hospital, Aarhus
Program of Transplant and cellular immunotherapy, Department of Hematology, Institut Paoli Calmettes, Marseille
University of Freiburg, Dept. of Medicine-Hematology, Oncology, Freiburg
Antwerp University Hospital, Edegem
Bone Marrow Transplantation Program, Department of Internal Medicine, American University of Beirut, Beirut, Lebanon
EBMT Paris Study Unit, Hôpital Saint Antoine, Paris, France; Sorbonne Université Service d' Hématologie Clinique et Thérapie Cellulaire, Hospital Saint-Antoine, Centre de Recherche Saint-Antoine (CRSA), Paris
Hematology Division, Chaim Sheba Medical Center, Tel-Hashomer
Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
EBMT Paris Study Unit, Hôpital Saint Antoine, Paris, France; Department of Hematology and Cell Therapy, Hopital Saint Antoine and Université Paris Sorbonne, Paris
Bone Marrow Transplantation Center, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou
Unit of Hematology and Stem Cell Transplantation, Ospedale San Raffaele, University Vita-Salute San Raffaele, Milan
EBMT Paris Study Unit, Hôpital Saint Antoine, Paris, France; Department of Hematology and Cell Therapy, Hopital Saint Antoine and Université Paris Sorbonne, Paris
Haematologica Early view Jun 19, 2025 https://doi.org/10.3324/haematol.2025.287326

Abstract

Not available.

Figures & Tables

Article Information

Early view : Letters to the Editor
 
DOI
https://doi.org/10.3324/haematol.2025.287326
Pubmed
40534491
 
Published
2025-06-19
Published By
Ferrata Storti Foundation, Pavia, Italy
Print ISSN
0390-6078
Online ISSN
1592-8721
 
Copyright & Usage
Copyright (c) 2025 Ferrata Storti Foundation
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Article Usage

Online Views
174
PDF Downloads
106

Statistics from Altmetric.com

No Data
Navigate
For Authors
For Reviewers
For Advertisers
Education
Privacy
More
Copyright © 2025 by the Ferrata Storti Foundation | Web design ￫ | Development ￫
ISSN 0390-6078 print | ISSN 1592-8721 online